DOUBLE-BLIND, MULTI-CENTRE PARALLEL TRIAL OF KETOPROFEN AND IBUPROFEN IN TREATMENT OF RHEUMATOID-ARTHRITIS

  • 1 January 1977
    • journal article
    • research article
    • Vol. 4  (2) , 153-157
Abstract
A double-blind parallel multi-center study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new nonsteroidal, anti-inflammatory agent, over a 3 mo. period. Ketoprofen was well tolerated and had comparable efficacy with ibuprofen.

This publication has 0 references indexed in Scilit: